Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

IPAB Rejects Novartis Plea for New Tech Member (India)

This article was originally published in PharmAsia News

Executive Summary

The Intellectual Property Appellate Board (IPAB) in India has dismissed the application by Novartis to appoint a new technical member in place of former Patent Controller S Chandrasekhar to hear the pharma firm's appeal against the Patent Office's denial of patent to its blood cancer drug Glivec. Novartis officials said Chandrasekhar had a conflict of interest due to being the Patent Controller who denied the patent rights for Glivec. A Novartis spokesperson said, "Today's decision was a summary judgment and we will not know the panel's reasoning until a full written judgment is issued. We will consider our options once we see the full text." (Click here for more
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC066377

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel